http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5158963-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f8a8f16522cbf08213cf1ab3ff3dd6d8 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-90 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D211-90 |
| filingDate | 1990-07-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1992-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b81a1545ac1668cb7f1a8a8aa1e15454 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_382d125d7656a7475f7aead2ff3d71fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf6e6aa96f6b73c1cba0163b29027785 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_451e551af54a60a0af9f4a5c1405ae78 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb76f0f0bbe215f628bff943541c3895 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3727a2224aaad8a41421a210b8fe7990 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d22e3fc91fb596d9bdbf47a700f3329c |
| publicationDate | 1992-10-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-5158963-A |
| titleOfInvention | 1-4-dihydropyridine derivative, process for preparing the same and pharmaceutical composition containing the same |
| abstract | A 1,4-dihydropyridine derivative having the formula (I): ##STR1## wherein X is oxygen atom or nitrogen atom; when X is oxygen atom, R 1 is hydrogen atom, a lower alkyl group, a lower cycloalkyl group, a lower alkenyl group or magnesium atom, when X is nitrogen atom, X-R 1 group is NH 2 , NHR 1' , NR 1' R 1" or ##STR2## in which R 1' is a lower alkyl group or a lower alkoxyalkyl group, R 1" is a lower alkyl group and n is an integer of 2 to 6; R 2 is a lower alkyl group, a lower cycloalkyl group or a lower alkoxyalkyl group and R 3 is a lower alkyl group, formyl group, dimethoxymethyl group, cyano group or amino group, when X is oxygen atom and R 1 is hydrogen atom or magnesium atom, R 3 is methyl group, when X is nitrogen atom, R 3 is methyl group, or a pharmaceutically acceptable salt thereof, some processes for preparing the same and a pharmaceutical composition containing the same. According to the present invention, a superior cerebral function improver can be provided. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6211198-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5767131-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6608086-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6310076-B1 |
| priorityDate | 1989-08-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 481.